Evidence-Based GI
Swathi Eluri, MD, MSCR takes an evidence-based look at a 2022 article which showed budesonide oral suspension improved outcomes in patients with EoE.
Multi-Target Stool DNA Test for CRC Screening: How Accurate is the New Version? Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief…
Linaclotide Effective for Functional Constipation in 6-17 Year Olds: First FDA-Approved Constipation Treatment for Children Ahmad Abu-Heija, MBBS Consultant Gastroenterologist,…
PROFILE: Can Molecular Biomarkers Predict Outcomes to Crohn’s Disease Treatment? Bharati Kochar, MD, MS Assistant Professor of Medicine, Division of…
Cell-free DNA Blood Test for CRC Screening: A Promising Development Won’t “Eclipse” Current Tools Philip Schoenfeld, MD, MSEd, MSc (Epi)…
First FDA-Approved NASH Treatment Produces NASH Resolution and Decreases Fibrosis: Results From the Landmark Phase 3 MAESTRO-NASH Trial Phillip Leff,…
How Effective are Obesity Medications for Reducing Hepatic Decompensation in MASH? Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus), Gastroenterology…
Ustekinumab and Vedolizumab Demonstrate Safety During Pregnancy-Updates From the PIANO Registry Rahul Dalal, MD, MPH Instructor, Division of Gastroenterology, Hepatology,…
Are you passionate about evidence-based research in gastroenterology (GI) and dedicated to advancing the field through application of scholarly research…
March 2024 Colorectal Cancer Awareness—The Year in Review Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus), Gastroenterology Section, John D.…